Beetham Eye Institute at Joslin Diabetes Center Cited for Outstanding Treatment for Diabetic Retinopathy
BOSTON – (March 12, 2014) – The Beetham Eye Institute (BEI) at Joslin Diabetes Center has been recognized as one of the top institutions worldwide for research and treatment of diabetic retinopathy by Expertscape. In addition, Lloyd P. Aiello, M.D., Ph.D., Director of the BEI and Professor of Ophthalmology at Harvard Medical School has been recognized as one of the top three specialists in diabetic retinopathy worldwide.
Lloyd P. Aiello, M.D., Ph.D., Director of the Beetham Eye Institute and Professor of Ophthalmology at Harvard Medical School .
“This recognition is a tribute to the breadth and depth of the contribution of all members of the BEI, the Vascular Cell Biology & Eye Research Sections and Joslin as a Harvard Medical School institution supporting all our academic endeavors,” commented Dr. Aiello. “Without the exceptional contributions of individuals such as George King, M.D., Chief Scientific Officer and Senior Vice President at Joslin, Ed Feener, Ph.D., Investigator in the Section on Vascular Cell Biology and Director of the Proteomics Core at Joslin, and every member of the BEI, neither Joslin nor I could have attained this extent of visibility in our area of expertise.”
Expertscape produces its medical search and ranking solution using an objective algorithm to identify the most knowledgeable and experienced physicians, clinicians and researchers across over 26,000 specific topics, stratified by geography. Rankings are reportedly 100 percent objective, based on number and quality of publications, journals and publication type.
“I think it is exciting how much progress can be made when many parts of the Joslin work together,” said Dr. Aiello. “It is a unique environment at Joslin where a high-end research department and a high-end clinical department can work so closely together and where this approach is supported by the administrative leadership. This special environment is what keeps so many of us here and committed to our mission.”